Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Histamine Blockade and Muscle Transcriptome Response to Training
NCT05131555Completed
- Sponsor
- Ghent University
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of fexofenadine and famotidine, sponsored by Ghent University. Primary endpoints: Change in muscle transcriptome (direct response) and Change in muscle transcriptome (delayed response). Started Aug 2021; status: completed.
02
Drugs
fexofenadinefamotidine
Beyond the preview
Go deeper on NCT05131555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05131555.